( November 26, 2024, 12:15 PM EST) -- WILMINGTON, Del. — A federal judge in Delaware almost entirely denied a summary judgment motion filed by a defendant biopharmaceutical company, holding that a reasonable jury could find that the company had infringed upon the plaintiff company’s patented immunotherapy regimen used in treating cancer....